Atlas de poche de physiologie. 4 e éd. Flammarion Médecine-Sciences, 2008. ,
Contribution à l'étude du pouvoir immunomodulateur des bifidobactéries: analyse in vitro et étude ex vivo des mécanismes moléculaires impliqués [Internet]. [cité 2011 oct 6];Available from, MICI%200809.pdf 4. Digestion_L2_Support_du_cours.pdf (Objet application/pdf) [Internet]. [cité 2011 oct 6];Available from Liste des bactéries pathogènes [Internet]. Bioltrop. [cité 2011 oct 11];Available from, 2005. ,
Available from: http://www.institutdanone.org/objectif-nutrition/composition-et-roles-de-la-flore-intestinale- mieux-connaitre-son-importance/dossier-composition-et-roles, Internet]. [cité 2011 oct 4] ,
Microbial Influences in Inflammatory Bowel Diseases, Gastroenterology, vol.134, issue.2, pp.577-94, 2008. ,
DOI : 10.1053/j.gastro.2007.11.059
Flore microbienne intestinale Physiologie et pathologie digestives, 2004. ,
France: Vigot, 1994. ,
A human gut microbial gene catalogue established by metagenomic sequencing, Nature, vol.13, issue.7285, pp.59-65 ,
DOI : 10.1038/nature08821
URL : https://hal.archives-ouvertes.fr/cea-00908974
Maladies inflammatoires chroniques de l'intestin.Progrès en hépato-gastro entérologie ,
Microbial Influences in Inflammatory Bowel Diseases, Gastroenterology, vol.134, issue.2, pp.577-94, 2008. ,
DOI : 10.1053/j.gastro.2007.11.059
The Role of Microbes in Crohn's Disease. Clinical Infectious Diseases, janv, vol.1544, issue.2, pp.256-62, 2007. ,
Symbiotic gut microbes modulate human metabolic phenotypes, Proceedings of the National Academy of Sciences, vol.105, issue.6, pp.2117-2139, 2008. ,
DOI : 10.1073/pnas.0712038105
Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health, World Journal of Gastroenterology, vol.15, issue.1, pp.81-86, 2009. ,
DOI : 10.3748/wjg.15.81
Mucosal flora in inflammatory bowel disease, Gastroenterology, vol.122, issue.1, pp.44-54, 2002. ,
DOI : 10.1053/gast.2002.30294
Role of the faecal stream in the maintenance of Crohn's colitis. Gut. 1985 mars, pp.279-84 ,
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum, The Lancet, vol.338, issue.8770, pp.771-775, 1991. ,
DOI : 10.1016/0140-6736(91)90663-A
Is Crohn's disease due to defective immunity? Gut, pp.2-5, 2007. ,
Reduced ??-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease, Gut, vol.57, issue.7, pp.903-913, 2008. ,
DOI : 10.1136/gut.2007.142588
Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection, Gastroenterology, vol.108, issue.6, pp.1617-1638, 1995. ,
DOI : 10.1016/0016-5085(95)90121-3
The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1720-1728, 2011. ,
DOI : 10.1053/j.gastro.2011.01.054
Functional variants of OCTN cation transporter genes are associated with Crohn disease, Nature Genetics, vol.36, issue.5, pp.471-476, 2004. ,
DOI : 10.1038/ng1339
Place des biothérapies dans la prise en charge des MICI :Etude rétrospective évaluant le profil et le type de prise en charge des patients traités par infliximab (efficacité et tolérance)au CHU de Grenoble de 2000 à 2008. Grenoble; 2009. 39. Les Maladies Inflammatoires Chroniques de l'Intestin (MICI) Aspects immunologiques [Internet]. [cité 2011 déc 12];Available from: http://pharmaweb.univ- lille2.fr/apache2-default, Gastroenterol Clin Biol, vol.40, pp.262-71, 2006. ,
Nutritional consequences and nutrition therapy in Crohn's disease. Gastroentérologie Clinique et Biologique, pp.235-279, 2009. ,
Conséquences nutritionnellesdes maladies inflammatoirescryptogénétiquesde l'intestin. La lettre de l'hepatogastro entérologue, 2003. ,
Nutritional deficiencies in patients with Crohn??s disease in remission, Inflammatory Bowel Diseases, vol.12, issue.3, pp.185-91, 2006. ,
DOI : 10.1097/01.MIB.0000206541.15963.c3
Nutritional status and nutritional therapy in inflammatory bowel diseases, World Journal of Gastroenterology, vol.15, issue.21, pp.2570-2578 ,
DOI : 10.3748/wjg.15.2570
Vitamin status in patients with inflammatory bowel disease, Am. J. Gastroenterol, vol.84, issue.7, pp.744-752, 1989. ,
Vitamin D, NOD2, autophagy and Crohn???s disease, Expert Review of Clinical Immunology, vol.6, issue.4, pp.505-513, 2010. ,
DOI : 10.1586/eci.10.31
Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases, AJP: Gastrointestinal and Liver Physiology, vol.300, issue.2, pp.191-201, 2011. ,
DOI : 10.1152/ajpgi.00496.2010
Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease, Journal of Clinical Microbiology, vol.44, issue.11, pp.3980-3988, 2006. ,
DOI : 10.1128/JCM.00312-06
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach, Gut, vol.55, issue.2, pp.205-216, 2006. ,
DOI : 10.1136/gut.2005.073817
Therapeutic correction of bacterial dysbiosis discovered by molecular techniques, Proceedings of the National Academy of Sciences, vol.105, issue.43, pp.16413-16417, 2008. ,
DOI : 10.1073/pnas.0809363105
Specificities of the fecal microbiota in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.12, issue.2, pp.106-117, 2006. ,
DOI : 10.1097/01.MIB.0000200323.38139.c6
The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique, Journal of Medical Microbiology, vol.35, issue.4, pp.238-281, 1991. ,
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proceedings of the National Academy of Sciences, vol.105, issue.43, pp.16731-16737, 2008. ,
DOI : 10.1073/pnas.0804812105
URL : https://hal.archives-ouvertes.fr/hal-00652961
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn???s disease, Gastroenterology, vol.127, issue.2, pp.412-433, 2004. ,
DOI : 10.1053/j.gastro.2004.04.061
Treatment of inflammatory bowel disease: A review of medical therapy The ideal management of Crohn's disease: top down versus step up strategies, a randomizedcontrolled trialAvailable from: http://www.efsa.europa.eu/fr/faqs/faqnutrition.htm 64. OMS | L'Europe met les allégations de santé à l'épreuve [Internet]. OMSAvailable from: http://www.eufic.org/article/fr/nutrition/aliments- fonctionnels/artid/Bacteries-probiotiques-recherches-poursuivent/ 66. Flore intestinale et probiotiques_PRADINES-PAGES.pdf (Objet application/pdf) [Internet], A108. 63. EFSA: FAQ sur les allégations nutritionnelles et de santé [Internet]. [cité 2011 oct 18] Bactéries probiotiques ? les recherches se poursuivent? (EUFIC) [Internet]. [cité 2011 oct 18]Flore%20intestinale%20et%20probiotiques_PRADINES- PAGES.pdf 67. D'Adamo,Kelly. Les probiotiques et le rôle de votre groupe sanguin [Internet]. nutritionk21, pp.354-77, 2006. ,
07 BullMICI -Probiotiques et MICI : faut-il y croire?, 2007. ,
Probiotiques: les bactéries sont-elles réellement nos amies? Health and food, 2005. ,
Pays Bas) World Gastroenterology Organisation mondiale de Gastroentérologie Recommandation Pratique: Probiotiques et Prébiotiques Probiotiques -Prébiotiques -Symbiotiques (2/2) -Globepharma [Internet]. globepharma. [cité 2011 oct 19];Available from: http://globepharma.over-blog.com/article- probiotiques-prebiotiques-symbiotiques-2-2-63285043.html 73. fiche conseil prébiotiques,probiotiques [Internet]. pharmaciedelepoulle. [cité Invited review: Application of omics tools to understanding probiotic functionality, J. Dairy Sci, vol.7294, issue.10, pp.4753-65, 2008. ,
Probiotics and immune health, Current Opinion in Gastroenterology, vol.27, issue.6, pp.496-501, 2011. ,
DOI : 10.1097/MOG.0b013e32834baa4d
lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes, Proceedings of the National Academy of Sciences, pp.18132-18139, 2010. ,
Saccharomyces boulardii in maintenance treatment of Crohn's disease, Digestive Diseases and Sciences, vol.45, issue.7, pp.1462-1466, 2000. ,
DOI : 10.1023/A:1005588911207
Probiotiques et MICI, Hépato Gastro, vol.14, pp.49-54, 2007. ,
Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea, a pilot study, Z gastroenterol, issue.31, pp.129-163, 1993. ,
Combination of antibiotic and probiotic treatment is efficacious in prophylaxisof post-operative recurrence of Crohn's disease: a randomised controlled study vs mesalamine, Gastroenterology, vol.118, 2000. ,
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?, Gastroent??rologie Clinique et Biologique, vol.33, pp.228-262, 2009. ,
DOI : 10.1016/S0399-8320(09)73158-6
URL : https://hal.archives-ouvertes.fr/hal-00816363
Failure of Synbiotic 2000 to Prevent Postoperative Recurrence of Crohn???s Disease, Digestive Diseases and Sciences, vol.21, issue.2, pp.385-394, 2007. ,
DOI : 10.1007/s10620-006-9549-7
Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG, Gut, vol.51, issue.3, pp.405-414, 2002. ,
DOI : 10.1136/gut.51.3.405
Probiotiques et maladies inflammatoires chroniques intestinales : à la conquête des pochites ? Gastroenterologie clinique et biologique, p.621, 2004. ,
DOI : 10.1016/s0399-8320(04)95027-0
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease, Lactobacillus GG in inducing and maintaining remission of Crohn's disease, pp.5-88833, 2004. ,
souche Lactobacillus casei DN-114 001 : résultats d'une étude clinique européenne multicentrique en double aveugle Gastroentérologie Clinique et Biologique Supplement 1):A135. 90 Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease, Aliment. Pharmacol. Ther, vol.3331, issue.38, pp.802-811, 2009. ,
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, vol.53, issue.1, pp.108-122, 2004. ,
DOI : 10.1136/gut.53.1.108
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial, Gastroenterology, vol.119, issue.2, pp.305-314, 2000. ,
DOI : 10.1053/gast.2000.9370
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial, The Lancet, vol.354, issue.9179, pp.635-644, 1999. ,
DOI : 10.1016/S0140-6736(98)06343-0
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine, Gut, vol.53, issue.11, pp.1617-1640, 2004. ,
DOI : 10.1136/gut.2003.037747
De la phisiologie (intégrée) à la pathologie Nouvelles voies de recherche. Gastroentérologie [Internet]. [cité 2011 oct 14];Available from: http://psydoc-fr.broca.inserm.fr/colloques/cr The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice, Gastroenterology, vol.141, issue.609, pp.599-609, 2011. ,
Hypnotherapy as an Adjuvant for the Management of Inflammatory Bowel Disease: A Case Report, American Journal of Clinical Hypnosis, vol.91, issue.3, pp.255-62, 2009. ,
DOI : 10.1080/00029157.1997.10403415
Alimentation pauvre en fibres, 2010. ,
Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial, Scandinavian Journal of Gastroenterology, vol.33, issue.1, pp.778-85, 1996. ,
DOI : 10.3109/00365529609010352
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease, New England Journal of Medicine, vol.334, issue.24, pp.1557-60, 1996. ,
DOI : 10.1056/NEJM199606133342401
La glutamine associée à l'arginine diminue l'inflammation intestinale ex vivo chez des patients atteints de maladie de Crohn colique en poussée, 2008. ,
Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial, Am. J. Gastroenterol, vol.98, issue.2, pp.348-53, 2003. ,
Available from: http://www.eurekasante.fr/ 110. Homeophyto.com | Stress et troubles anxieux [Internet]. homeophyto.com le magazine de l'homeopathie et de la phytotherapie, 2011. ,
2010 juill [cité 2011 oct 14];Available from: http://www.passeportsante.net/fr/Solutions/PlantesSupplements/Fiche.aspx?doc=magnesium_ ps ,
Antidepressant- and anxiolytic-like activity of magnesium in mice, Pharmacology Biochemistry and Behavior, vol.78, issue.1, pp.7-12, 2004. ,
DOI : 10.1016/j.pbb.2004.01.006
Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior, Amino Acids, vol.8, issue.4, pp.1231-1279, 2011. ,
DOI : 10.1007/s00726-010-0758-1
Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment, Neuropharmacology, vol.62, issue.1, 21835188. ,
DOI : 10.1016/j.neuropharm.2011.07.027
Severe hypomagnesemia and low-grade inflammation in metabolic syndrome, Magnes Res. 2011 juin, vol.124, issue.2, pp.45-53 ,
Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action, Pharmacol Rep, vol.60, issue.5, pp.588-597, 2008. ,
for the Relief of Anxiety-Related Premenstrual Symptoms: A Randomized, Double-Blind, Crossover Study, Journal of Women's Health & Gender-Based Medicine, vol.9, issue.2, pp.131-140, 2000. ,
DOI : 10.1089/152460900318623
Available from: http://www.hassante.fr/portail/jcms/c_815923/magne-b6-uvimag-b6-magnesium-vitamine-b6-synthese-d- avis 120, Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, 2008. ,
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions, Nature Neuroscience, vol.433, issue.3, pp.345-50, 2011. ,
DOI : 10.1126/science.1120972
URL : https://hal.archives-ouvertes.fr/hal-00612705